103 results
Page 2 of 6
PRE 14A
uwjpl89wam3
19 Apr 21
Preliminary proxy
5:28pm
424B5
ymwbgvwttjslxg6ik3g
11 Sep 20
Prospectus supplement for primary offering
4:44pm
424B5
rhm62dw5 vnn
9 Sep 20
Prospectus supplement for primary offering
4:40pm
8-K
EX-10.1
s3efsf
28 May 20
Departure of Directors or Certain Officers
4:16pm
8-K
EX-99.1
nheqv6t1h48q3
7 May 20
Intra-cellular Therapies Reports First Quarter 2020 Financial Results and Provides Corporate Update
7:42am
8-K
bgfagdrx
23 Mar 20
Intra-Cellular Therapies Announces Availability of CAPLYTA™ (lumateperone) for Adult Patients with Schizophrenia
7:52am
8-K
EX-99.1
h9e4ab6943qcsqffc8d
2 Mar 20
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2019 Financial Results and Provides Corporate Update
7:43am
424B5
023bz50kl0q5j0w
8 Jan 20
Prospectus supplement for primary offering
5:06pm
8-K
EX-99.3
h93fgsatjoym
6 Jan 20
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
4:52pm